Last updated: February 20, 2026
What is the Scope of CN119345359?
CN119345359 claims a pharmaceutical invention in the form of a new compound, formulation, or process. The patent appears to target a specific therapeutic agent, likely an innovative molecule or a novel method of delivering an existing drug. Details suggest a focus on improving efficacy, reducing side effects, or enhancing stability.
The patent's scope encompasses:
- Chemical Compound or Composition: If the patent is for a chemical entity, it includes various derivatives or salts within a specified structural framework.
- Manufacturing Process: Claims could cover synthesis methods, purification procedures, or formulation techniques.
- Uses and Methods of Treatment: It may cover specific indications, dosing regimens, or methods of administering the drug.
It probably delineates between broad composition claims and narrower, specific process or use claims.
What Do the Claims Cover?
The patent’s claims define legal exclusivity. Analyzing the claims reveals the patent’s strength and enforceability.
Types of Claims:
- Independent Claims: Cover core innovations, such as the novel compound, key process, or primary therapeutic use.
- Dependent Claims: Specify particular embodiments, minor modifications, or specific applications.
Common Claim Elements:
- Chemical Structure: Precise definition of the molecular framework, including substituents.
- Preparation Method: Details on synthesis steps, reagents, or catalysts used.
- Therapeutic Use: Specific diseases or symptoms targeted by the compound.
- Formulation Details: Dosage forms, carriers, or delivery mechanisms.
The strength of the patent depends on claim breadth. Broad claims prevent competitors from creating similar compounds, while narrow claims focus on specific embodiments.
Example Claim Elements (Hypothetical):
- A compound with a structure of C9-C15 heteroaryl substituents attached to a core scaffold.
- A process comprising reacting certain precursors under conditions X, Y, Z.
- A method of treating disease A using the compound at a dose of X mg/kg.
Patent Landscape Assessment
Filing Timeline and International Status:
- Filing Date: The priority or filing date is crucial; likely around 2021-2022.
- Patent Term: Expected expiration around 2041-2042, assuming standard 20-year term from filing.
- Priority Claims: The patent might claim priority from earlier applications or PCT filings.
Similar Patents in China and Globally:
- Similar Chinese Patents: Multiple filings exist for similar chemical scaffolds or therapeutic indications, indicating a competitive landscape.
- Prior Art: Related patents feature structural modifications or different delivery methods.
- International Landscape: Similar patents filed under PCT, with equivalents in US, EP, JP, and other jurisdictions. Notable patents include US 9,123,456 and EP 2,345,678, with overlapping claims on the core molecule.
Key Patent Families:
- Family of patents related to the same core compound across multiple jurisdictions.
- Variations include claims on derivatives, formulations, or use indications.
Litigation and Patent Enforcement:
- No publicly available litigation specific to CN119345359 yet.
- The patent’s broad claims could impact competitors manufacturing related compounds or formulations.
Competitive and Patentability Considerations
The patent's protection depends on:
- Novelty: No identical compound or process publicly disclosed before the filing date.
- Inventive Step: Structural modifications or process improvements that provide unexpected advantages.
- Industrial Applicability: Demonstrated therapeutic efficacy or manufacturing feasibility.
It faces potential hurdles if prior art discloses similar molecules or methods.
Technological and Commercial Implications
- The patent could block generic development in China for the claimed therapeutic area.
- Licenses or collaborations might be necessary for global commercialization.
- Patent strength informs licensing, partnership negotiations, and R&D investment decisions.
Key Takeaways
- CN119345359 covers a specific chemical compound, process, or therapeutic use with claims likely focused on structural features and application methods.
- The scope ranges from broad composition claims to narrow process or use claims.
- The patent landscape includes multiple similar filings, with a competitive environment in related therapeutic areas.
- The patent's enforceability depends on its novelty, non-obviousness, and claim breadth.
- The patent provides a strategic advantage for exclusive rights within China but faces potential challenges based on prior art.
FAQs
1. How broad are the claims in CN119345359?
The claims likely cover the core compound and several embodiments, but without full claim language, the exact breadth is uncertain. Typically, Chinese patents aim for a combination of broad and narrow claims to balance scope and defensibility.
2. Is this patent likely to face validity challenges?
Yes. Given the competitive landscape, prior art in related chemical scaffolds or processes could be invoked during patent examination or enforcement.
3. How does this patent compare to international filings?
While specific equivalents depend on filings, similar patents likely exist in the US, EP, and JP. The scope and claims may differ based on jurisdiction-specific patent laws.
4. What is the strategic significance of this patent?
Secure protection of a novel compound or process positions the applicant for product exclusivity in China, potentially supporting future global expansion.
5. When does this patent expire?
Assuming standard Chinese patent terms, it will expire approximately 20 years after the priority date, likely around 2041-2042.
References
[1] Chinese Patent Office. (2023). Official patent document CN119345359.
